Larry Goldkind MD is a gastroenterologist with over twenty years of clinical experience in addition to over ten years experience in drug development and regulatory science. He spent five years at the FDA, initially as a medical officer in the Gastroenterology division and subsequently as acting Division Director of the Division of Anti-inflammatory and Analgesic Drug Products from 2000-2003.